What is the recommended endoscopic treatment for Primary Sclerosing Cholangitis (PSC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Endoscopic Treatment of Primary Sclerosing Cholangitis

Balloon dilation alone is the preferred first-line endoscopic treatment for dominant strictures in PSC, with stenting reserved only for strictures that fail to respond to balloon dilation. 1, 2

When to Perform ERCP

ERCP should not be performed until after expert multidisciplinary assessment and confirmation of a therapeutic indication. 1 Magnetic resonance cholangiography (MRCP) must be performed first as the primary diagnostic modality, not ERCP. 1, 3

Specific Indications for Therapeutic ERCP:

  • Symptomatic deterioration: New or worsening jaundice, cholangitis (fever/chills), or progressive pruritus 1
  • Biochemical progression: Rapid increase in serum bilirubin or cholestatic enzymes (alkaline phosphatase, GGT) 1
  • Imaging findings: New dominant stricture or progression of existing dominant strictures on MRCP with appropriate clinical context 1

Important caveat: Do not use CA19-9 elevation alone to trigger ERCP—it has poor sensitivity (14%) and positive predictive value (67%) for cholangiocarcinoma. 1

Pre-Procedure Requirements

Mandatory Steps Before ERCP:

  • Prophylactic antibiotics must be administered routinely before every ERCP in PSC patients 1, 2, 3
  • MRCP imaging should be performed before therapeutic ERCP to identify target strictures 1
  • Multidisciplinary review to confirm appropriateness of intervention 1

Endoscopic Treatment Algorithm

First-Line: Balloon Dilation Alone

Balloon dilation without stenting is the preferred initial approach for all dominant strictures. 1, 2 This recommendation is based on a randomized controlled trial (DILSTENT) that was prematurely stopped due to significantly higher serious adverse events with stenting (45%) compared to balloon dilation alone (7%). 1, 2

Technical Specifications:

  • Balloon size: 6-8 mm for hepatic ducts; up to 8 mm for common bile duct 2
  • Success criteria: Complete balloon inflation with no waist visible fluoroscopically, followed by unobstructed contrast passage 2
  • Repeat sessions: Typically requires 2-3 sessions at 1-4 week intervals, with 80-90% technical success rate 2, 4

Advantages of Balloon Dilation:

  • Lower complication rates (15% vs 54% with stenting) 2
  • Bile duct perforation rate only 0.2% 1, 2
  • Lower cholangitis risk compared to stenting 1, 5

Second-Line: Short-Term Stenting

Stenting should only be used when strictures fail to respond adequately to balloon dilation alone. 1, 2 If stenting is necessary, use short-term stenting rather than long-term stenting to minimize complications. 1, 2

Long-term stenting is associated with higher rates of stent clogging and cholangitis and should be avoided. 2

Biliary Sphincterotomy Decision

Do not perform routine biliary sphincterotomy—assess benefits versus risks on a case-by-case basis. 1, 3

When to Consider Sphincterotomy:

  • After difficult cannulation 1, 3
  • In patients likely to require multiple repeat ERCPs 2

Rationale: While sphincterotomy increases short-term adverse events in PSC, it may be protective for subsequent procedures. 2

Mandatory Tissue Sampling

Ductal sampling with brush cytology and endobiliary biopsies is mandatory during ERCP for any suspicious stricture. 1, 3 This is critical because cholangiocarcinoma develops in 10-20% of PSC patients. 6

Red Flags for Cholangiocarcinoma:

  • Worsening cholestasis with weight loss 1, 3
  • New or progressive dominant stricture 1, 3
  • Raised CA19-9 (though not specific) 1, 3
  • Associated enhancing mass lesion on imaging 1, 3

Procedural Technique to Minimize Complications

Aspirate bile before contrast injection during ERCP. 5 A prospective study demonstrated that bile aspiration prior to contrast injection, combined with balloon dilation without stenting, was associated with zero adverse events (0% vs 18.6% with traditional approach). 5

On multivariate analysis, biliary stent placement was the only factor independently associated with increased risk of adverse events (OR 4.10) and cholangitis (OR 5.43). 5

Follow-Up Strategy

Multiple dilations are typically required over months to years to maintain stricture patency. 1 In a large prospective study of 96 patients undergoing regular balloon dilations over 7 years, complication rates were low: 2.2% pancreatitis, 1.4% cholangitis, 0.2% perforation. 1

Common Pitfalls to Avoid

  • Do not perform ERCP as initial diagnostic test—always obtain MRCP first 1, 3
  • Do not place stents routinely—balloon dilation alone is safer and equally effective 1, 2
  • Do not skip tissue sampling—cholangiocarcinoma risk is substantial and unpredictable 1, 7, 3
  • Do not forget prophylactic antibiotics—cholangitis risk is significant in PSC 1, 2, 3
  • Do not inject contrast before aspirating bile—this increases adverse event risk 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.